161 related articles for article (PubMed ID: 28242790)
21. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
22. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data.
Gnerlich J; Jeffe DB; Deshpande AD; Beers C; Zander C; Margenthaler JA
Ann Surg Oncol; 2007 Aug; 14(8):2187-94. PubMed ID: 17522944
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
24. Factors responsible for long-term survival in metastatic breast cancer.
Kontani K; Hashimoto S; Murazawa C; Norimura S; Tanaka H; Ohtani M; Fujiwara-Honjo N; Date M; Teramoto K; Houchi H; Yokomise H
World J Surg Oncol; 2014 Nov; 12():344. PubMed ID: 25395387
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with mortality after breast cancer metastasis.
Jung SY; Rosenzweig M; Sereika SM; Linkov F; Brufsky A; Weissfeld JL
Cancer Causes Control; 2012 Jan; 23(1):103-12. PubMed ID: 22037907
[TBL] [Abstract][Full Text] [Related]
26. The impact of nodal micrometastasis on mortality among women with early-stage breast cancer.
Iqbal J; Ginsburg O; Giannakeas V; Rochon PA; Semple JL; Narod SA
Breast Cancer Res Treat; 2017 Jan; 161(1):103-115. PubMed ID: 27796715
[TBL] [Abstract][Full Text] [Related]
27. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
[TBL] [Abstract][Full Text] [Related]
28. Hospice use by older women dying with breast cancer between 1991 and 1996.
Lackan NA; Freeman JL; Goodwin JS
J Palliat Care; 2003; 19(1):49-53. PubMed ID: 12710115
[TBL] [Abstract][Full Text] [Related]
29. Risk of cardiac death after adjuvant radiotherapy for breast cancer.
Giordano SH; Kuo YF; Freeman JL; Buchholz TA; Hortobagyi GN; Goodwin JS
J Natl Cancer Inst; 2005 Mar; 97(6):419-24. PubMed ID: 15770005
[TBL] [Abstract][Full Text] [Related]
30. Improvement in breast cancer outcomes over time: are older women missing out?
Smith BD; Jiang J; McLaughlin SS; Hurria A; Smith GL; Giordano SH; Buchholz TA
J Clin Oncol; 2011 Dec; 29(35):4647-53. PubMed ID: 22067407
[TBL] [Abstract][Full Text] [Related]
31. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.
Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Borm GF; Tjan-Heijnen VC
Breast Cancer Res Treat; 2013 Oct; 141(3):507-14. PubMed ID: 24104881
[TBL] [Abstract][Full Text] [Related]
32. Palliative Care Interventions and End-of-Life Care for Patients with Metastatic Breast Cancer: A Multicentre Analysis.
Lucchi E; Berger F; Milder M; Commer JM; Morin S; Capodano G; Thomaso M; Fogliarini A; Bremaud N; Henry A; Mastroianni B; Chvetzoff G; Bouleuc C
Oncologist; 2024 May; 29(5):e708-e715. PubMed ID: 38387031
[TBL] [Abstract][Full Text] [Related]
33. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
[TBL] [Abstract][Full Text] [Related]
34. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.
Markt SC; Lago-Hernandez CA; Miller RE; Mahal BA; Bernard B; Albiges L; Frazier LA; Beard CJ; Wright AA; Sweeney CJ
Cancer; 2016 Oct; 122(20):3127-3135. PubMed ID: 27500561
[TBL] [Abstract][Full Text] [Related]
35. Age related influence of triple receptor status on metastatic breast cancer post relapse survival.
Todorovic-Rakovic N; Neskovic-Konstantinovic Z
J BUON; 2013; 18(4):851-8. PubMed ID: 24344008
[TBL] [Abstract][Full Text] [Related]
36. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States.
Mariotto AB; Etzioni R; Hurlbert M; Penberthy L; Mayer M
Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):809-815. PubMed ID: 28522448
[No Abstract] [Full Text] [Related]
37. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
38. Primary and secondary distant metastatic breast cancer: two sides of the same coin.
Güth U; Magaton I; Huang DJ; Fisher R; Schötzau A; Vetter M
Breast; 2014 Feb; 23(1):26-32. PubMed ID: 24215983
[TBL] [Abstract][Full Text] [Related]
39. Potential impact of USPSTF recommendations on early diagnosis of breast cancer.
Aragon R; Morgan J; Wong JH; Lum S
Ann Surg Oncol; 2011 Oct; 18(11):3137-42. PubMed ID: 21947591
[TBL] [Abstract][Full Text] [Related]
40. Prognosis of metachronous contralateral breast cancer according to stage at diagnosis: the importance of early detection.
Schootman M; Fuortes L; Aft R
Breast Cancer Res Treat; 2006 Sep; 99(1):91-5. PubMed ID: 16555124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
